Thursday, January 15, 2026
12:00 p.m. – 1:00 p.m. ET
Please note this TeleECHO program is 12:00 p.m. Eastern, 11:00 a.m. Central, 10:00 a.m. Mountain and 9:00 a.m. Pacific.
PRESENTING FACULTY
 |
Barry W. Rovner, MD Professor, Departments of Psychiatry & Neurology Sidney Kimmel Medical College Thomas Jefferson University Philadelphia, Pennsylvania |
PROGRAM OVERVIEW
The PREPARE TeleECHO Series is an interactive, case-based educational program designed to support clinicians in effectively integrating cognitive health screening into routine clinical practice. Led by experts in neurology, geriatrics, primary care, and psychiatry, the series emphasizes distinguishing normal aging from early cognitive decline using validated screening tools, updated clinical guidelines, and patient-centered communication strategies. The program equips clinicians with the skills to engage in meaningful discussions with patients and caregivers, navigate next steps including diagnostic testing, diagnosis, specialist referrals, and management planning, and implement practical tailored strategies to promote early detection and coordinated care that meets each patient’s unique needs.
TARGET AUDIENCE
This activity is tailored to address the educational needs of healthcare providers, excluding those located in the United Kingdom, who are involved in managing patients with cognitive health concerns. The primary audience includes primary care clinicians and general practitioners (MDs/DOs/NPs/PAs), general neurologists, and geriatricians, with a secondary audience of psychiatrists and OB-GYNs.
LEARNING OBJECTIVES
Upon completion of this program, attendees should be able to:
- Appraise cognitive health screening best practices to differentiate normal aging from early cognitive decline using validated tests, while offering appropriate management strategies and specialist referral
- Justify the use of clinical signs and symptoms, as well as biomarkers, to detect neuropathological changes in cognitive health conditions
- Model the integration of new data and guideline recommendations for cognitive health assessments into clinical practice
- Initiate conversations about cognitive health and cognitive preservation through patient and caregiver discussions and interdisciplinary communication across the cognitive health team
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
